<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Groningen_SpiroModel skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Groningen/SpiroModel</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV id="content_wrapper"><HEADER id="content-header"><SPAN id="logo-container" class="menu-item"><DIV class="menu-title"><A href="/Team:Groningen">CryptoGE®M</A></DIV></SPAN><SPAN class="menu-item"><DIV class="menu-title">Team</DIV><DIV class="sub-menu-wrap"><DIV class="sub-menu"><A href="/Team:Groningen/Team">Members</A><A href="/Team:Groningen/Supervisors">Supervisors</A><A href="/Team:Groningen/Collaborations">Collaborations</A><A href="/Team:Groningen/Achievements">Achievements</A><A href="/Team:Groningen/Contact">Contact</A></DIV></DIV></SPAN><SPAN class="menu-item"><DIV class="menu-title">Project</DIV><DIV class="sub-menu-wrap"><DIV class="sub-menu"><A href="/Team:Groningen/Tour"><STRONG>Tour</STRONG></A><A href="/Team:Groningen/Description">Description</A><A href="/Team:Groningen/Design">Design</A><A href="/Team:Groningen/Results">Results</A><A href="/Team:Groningen/Demonstrate">Demonstrate</A><A href="/Team:Groningen/Applications">Applications</A><A href="/Team:Groningen/FuturePerspectives">Future</A><A href="/Team:Groningen/Notebook">Notebook</A></DIV></DIV></SPAN><SPAN class="menu-item"><DIV class="menu-title">Biology</DIV><DIV class="sub-menu-wrap"><DIV class="sub-menu"><A href="/Team:Groningen/Experiments">Experiments</A><A href="/Team:Groningen/Parts">Parts</A><A href="/Team:Groningen/Safety">Safety</A><A href="/Team:Groningen/Labjournal">Lab journal</A></DIV></DIV></SPAN><SPAN class="menu-item"><DIV class="menu-title">Computing</DIV><DIV class="sub-menu-wrap"><DIV class="sub-menu"><A href="/Team:Groningen/Model">Modelling</A><A href="/Team:Groningen/Software">Software</A><A href="/Team:Groningen/Encoding">Encoding</A><A href="/Team:Groningen/Decoding">Decoding</A></DIV></DIV></SPAN><SPAN class="menu-item"><DIV class="menu-title">Human Practices</DIV><DIV class="sub-menu-wrap"><DIV class="sub-menu"><A href="/Team:Groningen/Human_Practices">Human Practices</A><A href="/Team:Groningen/HP/Gold">Gold</A><A href="/Team:Groningen/HP/Silver">Silver</A></DIV></DIV></SPAN><SPAN class="menu-item"><DIV class="menu-title">Support</DIV><DIV class="sub-menu-wrap"><DIV class="sub-menu"><A href="/Team:Groningen/Sponsors">Sponsors</A><A href="/Team:Groningen/Attributions">Attributions</A></DIV></DIV></SPAN></HEADER><DIV id="groningen-wrapper"><ARTICLE id="spiromodel" class="collapse-h2 collapse-conditional"><SECTION><H2>Choosing optimal strain for photoswitchable antibiotic </H2><P>As can be read in the <A href="/Team:Groningen/PhotoswitchableAntibiotics">photoswitchable 
		antibiotics</A> section, the idea with the photoswitchable antibiotic 
		was that it would kill the decoy <EM>B. subtilis</EM> but would not cause any 
		harm to the engineered strain containing the DNA sequence. </P><DIV class="split"><FIGURE class="left flone"><FIGCAPTION>Figure 1. Spirofloxacin photo-activation.</FIGCAPTION></FIGURE><FIGURE class="right flone"><FIGCAPTION>Figure 2. Spirofloxacin activity test. 1) LB agar with milliQ water as sterility control, 
				2-5) <EM>E. coli</EM> MC1061, DH5-alpha, BL4 and CS1562 strains.</FIGCAPTION></FIGURE></DIV><P>When not treated properly with the right wavelength of UV radiation 
		(see figure 1), spirofloxacin remains in its inactive state. Because 
		the sample sent to the receiver contains hundreds to thousands of times 
		more decoy spores, it cannot be sequenced directly by the recipient 
		(see also <A href="/Team:Groningen/DecodingFidelity">Decoding 
		Fidelity</A>). Instead, the receiver must activate the antibiotic. Once 
		done, the spirofloxacin-resistant message-containing bacteria would 
		outnumber the decoys.</P><P>We explored the activity of spirofloxacin on different strains of 
		<EM>E. coli</EM>, since it was a species of bacteria whose 
		susceptibility to spirofloxacin had been previously well measured <SUP id="ref-7"><A href="#cite-7">[7]</A></SUP> (see figure 2).</P><P>At this point of the lab work, experiments trying to measure the MIC 
		of spirofloxacin “on”/”off” against <EM>B. subtilis</EM> had been inconsistent. 
		We thought of Molecular Dynamics (MD) studies as a good alternative to 
		measure how well the antibiotic performs on Bacillus, thus allowing us 
		to continue faster with the engineering of the resistant strain.</P><P>It is important for our system that the ratio of resistance to 
		susceptibility in engineered and wild type is optimal. That means that 
		in its inactive state, spirofloxacin must not have a high bactericidal 
		activity and when activated, it must be potent enough to kill the 
		wild-type cells while the engineered strain will survive.</P><P>First, we needed to find a suitable crystallographic structure of a 
		type-II topoisomerase (a protein-DNA complex) bound to a 
		fluoroquinolone. Topoisomerase IV is the main fluoroquinolone’s target 
		in Gram-positive bacteria, while gyrase (the other type of 
		topoisomerase II) is the main target in Gram-negatives <SUP id="ref-1"><A href="#cite-1">[1]</A></SUP>. The 
		crystallographic structure recently reported by Veselkov et. al. (2016) 
		offered a good alternative as it has the two fluoroquinolone molecules 
		bound to the protein-DNA complex.</P><P>Secondly, we needed to create and adapt an appropriate force-field 
		that would reproduce the behavior of the binding process at a 
		reasonable computational cost. A force-field is a set of parameters 
		that tells the software (we used GROMACS v5.0.4) how each atom behaves 
		and interacts with others. As reported elsewhere <SUP id="ref-1"><A href="#cite-1">[1]</A></SUP><SUP id="ref-2"><A href="#cite-2">[2]</A></SUP> the binding 
		process involves cation- and hydrogen-bonding interactions that can 
		only be reproduced in the atomistic level. However, the computational 
		cost of simulating a 150 kDa protein (embedded in a solvated box) is 
		high enough to consider using lower-resolution scales. In addition, the 
		crystallographic structure already is a bound topoisomerase – 
		antibiotic complex, so there is no need for that high level of 
		resolution. Coarse-grained models are refined enough to offer insights 
		into the affinity of protein-ligand interactions (see i.e. <SUP id="ref-4"><A href="#cite-4">[4]</A></SUP>). Some 
		of the molecular parameters for the spiropyran part of the molecule 
		(the part that gives it is photoswitchable behavior) had been studied 
		elsewhere <SUP id="ref-9"><A href="#cite-9">[9]</A></SUP>; nevertheless, its parameterization into atomistic and 
		further coarse-grained requires some extra work. </P><FIGURE><FIGCAPTION>Figure 3: DNA in complex with topoisomerase IV and the 
			molecule levofloxacin (a member of the cipro- and spirofloxacin 
			family). The GROMOS 53a6 atomistic force-field is used, while for 
			the coarse-grained the MARTINI force-field (v2.2) developed by the 
			University of Groningen was used (not all beads shown). Origin PDB 
			code: 3RAE.</FIGCAPTION></FIGURE><P>While the MARTINI force-field has been adapted and optimized for 
		both proteins and DNA <SUP id="ref-3"><A href="#cite-3">[3]</A></SUP><SUP id="ref-6"><A href="#cite-6">[6]</A></SUP> it cannot reproduce cation- and 
		hydrogen-mediated binding of ligands. So our best method is to use 
		umbrella sampling in which basically the protein and the ligand are 
		artificially placed in its “correct” orientation and dragged away from 
		each other, measuring the Potential of Mean Force (PMF) <SUP id="ref-5"><A href="#cite-5">[5]</A></SUP>. </P><P>Before actually starting the umbrella simulations and due to the 
		lack of consistent experimental results, we decided to change the 
		photoswitchable antibiotic approach in our project. However, for the 
		sake of clarity in the next figure we show what we expected to obtain 
		from the simulations. </P><FIGCAPTION><FIGCAPTION>Figure 4. In the umbrella sampling method the 
			antibiotic is pulled away from the protein-DNA complex as marked by 
			the arrow. As a result, we expected to obtain a profile as shown in 
			the right side in which the spirofloxacin shows two binding 
			affinity’s profiles. (Molecule shown, PDB code: 3RAE)</FIGCAPTION></FIGCAPTION></SECTION><SECTION><H6>References</H6><UL><LI id="cite-1"><A href="#ref-1">[1]</A> Aldred, K., Kerns, R. and Osheroff, N. (2014). Mechanism of Quinolone Action and Resitance. Biochemistry, 53, 1565-1574</LI><LI id="cite-2"><A href="#ref-2">[2]</A> Lupala, C., Gomez-Gutierrez, P. and Perez, J. (2013). Molecular Determinants of the Bacterial Resistance to Fluoroquinolones: A Computational Study. Current Computer-Aided Drug Design, 9: 281-288</LI><LI id="cite-3"><A href="#ref-3">[3]</A> Monticelli, L., Kandasamy, S., Periole, X., Larson, R., Tieleman, P., and Marrink, S. (2008). The MARTINI Coarse-Grained Force Field: Extension to Proteins. J. Chem. Theory and Comput., 4(5): 819-834</LI><LI id="cite-4"><A href="#ref-4">[4]</A> Naughton, F., Kalli, A. and Sansom, M. (2016). Association of Peripheral Membrane Proteins with Membranes: Free Energy of Bingind of GRP1 PH Domain with Phosphatidylinositol Phosphate-Containing Model Membranes. J. Phys. Chem. Lett., 7(7): 1219-1224</LI><LI id="cite-5"><A href="#ref-5">[5]</A> Torrie, G. and Valleau, J. (1977). Nonphysical sampling distributions in Monte Carlo free-energy estimation: Umbrella sampling. J. Comput. Phys., 23(2): 187-199</LI><LI id="cite-6"><A href="#ref-6">[6]</A> Uusitalo, J., Ingólfsson, H., Akhshi, P., Tieleman, P., Marrink, S. (2015). Martini Coarse-Grained Force Field: Extension to DNA. J. Chem. Theory Comput., 11(8): 3932-3945</LI><LI id="cite-7"><A href="#ref-7">[7]</A> Velema, W., Hansen, M., Lerch, M., Driessen, A., Szymanski, W. and Feringa, B. (2015). Ciprofloxacin-Photoswitch Conjugates: A Facile Strategy for Photopharmacology. Bioconjugate Chemistry, 26: 2592-2597</LI><LI id="cite-8"><A href="#ref-8">[8]</A> Veselkov, D., Lapanogov, I., Pan, X., Selvarajah, J., Skamrova, G., Branstrom, A., Prasad, L., Fisher, M. and Sanderson, M. (2016). Structure of a quinolone-stabilized cleavage complex of topoisomerase IV from Klebsiella pneumoniae and comparison with a related Streptococcus pneumoniae complex. Acta Cryst. D72: 488-496</LI><LI id="cite-9"><A href="#ref-9">[9]</A> Zhai, GH., Yang, P., Wu, SM., Lei, YB. and Dou, YS. (2014). A semiclassical molecular dynamics of the photochromic ring-opening reaction of spiropyran. Chinese Chemical Letters, 25: 727-731</LI></UL></SECTION></ARTICLE></DIV><DIV id="page-footer" class="page-footer"><SECTION><H6>Team</H6><UL><LI><A href="/Team:Groningen/Team">Members</A></LI><LI><A href="/Team:Groningen/Supervisors">Supervisors</A></LI><LI><A href="/Team:Groningen/Collaborations">Collaborations</A></LI><LI><A href="/Team:Groningen/Achievements">Achievements</A></LI><LI><A href="/Team:Groningen/Contact">Contact</A></LI><LI><A href="/Team:Groningen/Jamboree">Jamboree</A></LI></UL></SECTION><SECTION><H6>Project</H6><UL><LI><A href="/Team:Groningen/Tour">Tour</A></LI><LI><A href="/Team:Groningen/Description">Description</A></LI><LI><A href="/Team:Groningen/Design">Design</A></LI><LI><A href="/Team:Groningen/Demonstrate">Demonstration</A></LI><LI><A href="/Team:Groningen/Summary">Summary</A></LI><LI><A href="/Team:Groningen/Applications">Applications</A></LI><LI><A href="/Team:Groningen/Results">Results</A></LI><LI><A href="/Team:Groningen/FuturePerspectives">Future Perspectives</A></LI></UL></SECTION><SECTION class="double"><H6>Biology</H6><DIV class="split"><UL class="left flone"><LI><A href="/Team:Groningen/Experiments">Experiments</A></LI><LI><A href="/Team:Groningen/Safety">Safety</A></LI><LI><A href="/Team:Groningen/Decoy">Decoy experiment</A></LI><LI><A href="/Team:Groningen/PhotoswitchableAntibiotics">Photoswitchable antibiotics</A></LI><LI><A href="/Team:Groningen/BrickCharacter">BioBrick Characterization</A></LI><LI><A href="/Team:Groningen/KeyDeletion">Key deletion</A></LI></UL><UL class="right flone"><LI><A href="/Team:Groningen/Proof">Proof of concept</A></LI><LI><A href="/Team:Groningen/Labjournal">Lab journal</A></LI><LI><A href="/Team:Groningen/PlasmidConstruction">Plasmid construction</A></LI><LI><A href="/Team:Groningen/Protocols">Protocols</A></LI><LI><A href="/Team:Groningen/Labjournal/PrimerList">Primer list</A></LI><LI><A href="/Team:Groningen/Notebook">Notebook</A></LI></UL></DIV></SECTION><SECTION><H6>Modelling</H6><UL><LI><A href="/Team:Groningen/Model">Modelling</A></LI><LI><A href="/Team:Groningen/MutationRates">Mutation Rates</A></LI><LI><A href="/Team:Groningen/RandomMutation">Random Mutation</A></LI><LI><A href="/Team:Groningen/AIModel">AI Agent model</A></LI><LI><A href="/Team:Groningen/DecodingFidelity">Decoding Fidelity</A></LI><LI><A href="/Team:Groningen/SpiroModel">Optimal Strain</A></LI></UL></SECTION><SECTION><H6>Computing</H6><UL><LI><A href="/Team:Groningen/Software">Software</A></LI><LI><A href="/Team:Groningen/Encoding">Encoder</A></LI><LI><A href="/Team:Groningen/Decoding">Decoder</A></LI><LI><A href="/Team:Groningen/FullCoding">Full Coding</A></LI></UL></SECTION><SECTION class="double"><H6>Human Practices</H6><DIV class="split"><UL class="left flone"><LI><A href="/Team:Groningen/Human_Practices">Human Practices</A></LI><LI><A href="/Team:Groningen/HP/Outreach">Outreach</A></LI><LI><A href="/Team:Groningen/HP/Social">Social</A></LI><LI><A href="/Team:Groningen/HP/Legal">Legal</A></LI><LI><A href="/Team:Groningen/HP/FutureScenarios">Future Scenarios</A></LI></UL><UL class="right flone"><LI><A href="/Team:Groningen/HP/Education">Education</A></LI><LI><A href="/Team:Groningen/Integrated_Practices">Integrated Practices</A></LI><LI><A href="/Team:Groningen/Engagement">Engagement</A></LI><LI><A href="/Team:Groningen/HP/Gold">Gold</A></LI><LI><A href="/Team:Groningen/HP/Silver">Silver</A></LI></UL></DIV></SECTION><SECTION><H6>Support</H6><UL><LI><A href="/Team:Groningen/Sponsors">Sponsors</A></LI><LI><A href="/Team:Groningen/Attributions">Attributions</A></LI></UL></SECTION></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>